Enliven: Challenges in Cancer Detection and Therapy | Open Access Journals | Open Access Articles



Editorial Board Member

"Dr. Marc POIROT has done his Master of Science on chemistry of biomolecules from Université Paul Sabatier, Toulouse, France and PhD from Université Paul Sabatier, Toulouse, France on Synthesis and use of specific ligands for the characterization and the purification of the antiestrogen binding protein. His Professional appointments include Sanofi Post-doctoral fellow, Sanofi Synthelabo, Labège France from 1991-1992, research scientist (tenure) Inserm U-397 in 1992, Visiting Scientist in the Steroid Hormone Section, LMCB, NIDDK/National Institute of Health, Bethesda, MD, USA in 1993- 1996, Founder and Chief Scientific Officer of the biotech company Affichem in 2003, « habilitation à diriger les recherches » (HDR), Université Paul Sabatier in 2004, Research Director, Inserm U-563 in 2004, Chief, team « Metabolism, oncogenesis and cell differentiation”, CPTP, Inserm U-563, Toulouse, France in 2007, Chief, team “Sterol metabolism and therapeutic innovations in oncology”, CRCT, UMR Inserm/University Toulouse III in 2011. Dr. Marc POIROT is a member of Groupe de recherche sur les lipides (GERLI), Société Française de Chimie Thérapeutique (SCT), American Association for Cancer Research (AACR), American Society of Pharmacology and Experimental Therapeutics (ASPET). "